...
首页> 外文期刊>Journal of the Medical Association of Thailand =: Chotmaihet thangphaet >Clinical significance of atypical glandular cells in cervical Papanicolaou smears.
【24h】

Clinical significance of atypical glandular cells in cervical Papanicolaou smears.

机译:宫颈Papanicolaou涂片中非典型腺细胞的临床意义。

获取原文
获取原文并翻译 | 示例
           

摘要

To determine the prevalence and the rate of clinically significant lesions in women with atypical glandular cells in cervical Papanicolaou smears.A retrospective study was performed from the cytologic database of Charoenkrung Pracharak Hospital. All cervical cytologic examinations with a diagnosis of atypical glandular cells (AGC) between January 2002 and December 2009 were identified. Medical records were reviewed to determine the clinical data. Cytologic and histologic follow-up was obtained to establish the presence of clinically significant lesions.One hundred eleven AGC Pap smears were identified from 47,347 Pap smears. The prevalence of AGC was 0.23% over the eight years of the period studied. Clinically significant lesions were diagnosed in 32.4% of the women, including invasive cancer in 18.3%. Women with AGC favor neoplasia were more likely to have clinically significant lesions (53.8%) than women with AGC not otherwise specified (20%, p = 0.003). The rate of clinically significant lesions in women aged 35 years or older (35.7%) was not statistically significant different from women younger than 35 years of age (20%, p = 0.356). All cases of invasive cancer were found in women aged 35 years or older Cervical adenocarcinoma was the most common invasive cancer found in the present study.Women with atypical glandular cells on Papanicolaou smears were correlated with significant risk for clinically significant lesions, including invasive cancer Initial evaluation should include colposcopy, directed biopsy, and endocervical curettage. Women with risk factors for endometrial cancer should have an endometrial sampling.
机译:为了确定宫颈Papanicolaou涂片中具有非典型腺细胞的女性的患病率和临床显着病变的发生率,从Charoenkrung Pracharak医院的细胞学数据库中进行了一项回顾性研究。确定了2002年1月至2009年12月之间所有诊断为非典型腺细胞(AGC)的宫颈细胞学检查。审查病历以确定临床数据。进行了细胞学和组织学随访,以确定存在临床意义的病变。从47,347例巴氏涂片中鉴定出110例AGC巴氏涂片。在研究期间的八年中,AGC的患病率为0.23%。在32.4%的女性中,诊断出具有临床意义的病变,包括浸润性癌的18.3%。具有AGC倾向性肿瘤的女性比没有另外指定的AGC女性(20%,p = 0.003)更有可能出现临床上显着的病变(53.8%)。 35岁以上女性(35.7%)的临床显着性病变发生率与35岁以下女性(20%,p = 0.356)无统计学差异。宫颈腺癌是本研究中发现的最常见的浸润癌,所有浸润癌病例均在35岁以上的女性中发现.Papanicolaou涂片中具有非典型腺细胞的女性与临床上显着病变的重大风险相关,包括浸润癌评估应包括阴道镜检查,定向活检和宫颈刮除术。有子宫内膜癌危险因素的女性应进行子宫内膜取样。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号